Clinical Trial Update: Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating alemtuzumab or tocilizumab in combination with etoposide and dexamethasone for adults with hemophagocytic lymphohistiocytosis (HLH) has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis
• Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• DEXAMETHASONE (Dexamethasone)
• Etoposide (Etoposide)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2024-01-17